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Summary.-The lognormal parametric statistical model can provide, for groups of
carcinoma cervix patients, good estimates of long-term survival fractions several
years earlier than would otherwise be possible. The present paper extends this
model work to head and neck cancer by using a minimum chi-squared test for good-
ness of fit (P > 0.05), to study the distribution of survival times of patients who died
with their cancer present. Some 12,000 case histories were available from 7 hospital
registries, 4 regional cancer registries and one national registry (the OPCS). All
histories were followed up for at least 10 years subsequent to treatment and could
be grouped into one of 8 cancer sites: antrum, floor of mouth, larynx, nasopharynx,
pyriform fossa, post cricoid, tonsil and tongue. The theoretical distributions
investigated were the lognormal, negative exponential and skew exponential. The
results showed that the lognormal provided the best overall fit to the data, although
the range of optimum values for the lognormal parameter, S, differed with cancer
site. The optimum range did, however, usually include the value S = 0 45. These
results will now permit the second stage of validation of the lognormal model to
proceed for head and neck cancers.
THE USE of parametric statistical
models to predict the long term survival
rates for groups of patients treated for
cancer was suggested many years ago,
Boag, 1948; Berkson and Gage, 1952;
Haybittle, 1959, 1965. Until recently,
however, the models could not be
adequately tested due to the lack of
patient data with sufficiently detailed
follow-up, and the lack of the computer
facilities necessary for the lengthy itera-
tive procedures. It has been shown that
a lognormal model of the type in Fig. 1
is the most consistent model for groups of
staged carcinoma cervix patients, when a
value is assumed for the lognormal
parameter S in the range S = 0-35-
S 0 40 (Mould and Boag, 1975).
The validation ofthis lognormal model
for carcinoma cervix, was made in 2
tests. Firstly, the actual survival time
distribution of each group of patients was
compared with the postulated analytical
form, choosing the model parameters to
give the best fit. The goodness of fit was
assessed using a minimum chi-squared
test. The optimum analytical form is
significant only in that it provides a good
empirical fit to the data. No biological
explanation is suggested for the pattern
oflognormality. Secondly, accepting only
the limited survival data which would
have been available a few years (2, 3 or 4
years) after the end of a 5-year treatment
period under review, the model was used
to predict the 10-year or 15-year survival
rates. The predicted values were then
compared with observed 1O-year and
15-year results, taking standard errors
into account.
The present paper extends this earlier
work (Mould and Boag, 1975) to include
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FIG. 1. Statistical model
cancers of the head and neck, but only
for the first of the 2 tests. Data for
those who died from anintercurrent disease
and those who are still alive has not yet
been collected by the authors, but the
survival times were available for some
12,000 patients, known to have died with
their cancer present, who have all been
followed up for at least 10 years subse-
quent to treatment. All patients had
a verified histology prior to initial treat-
ment.
LITERATURE SURVEY
Lognormality testing has previously
been attempted for head and neck cancers
by Boag (1948, 1949, 1951), Berg (1965)
and Wood and Boag (1950), and for cancer
at other sites by Tivey (1954), Sorensen
(1958), Smithers et al. (1952), Haybittle
(1959), Ronnike (1968) and Rabbe (see
Mould, 1975). The methods used to test
for goodness of fit have varied, and
T
00
N (t). dt = 1 0Or C
for cancer of the cervix.
SURVIVAL TIME ( t )
and Q =J(N (t). dt
although a x2 test using a single set of
estimated lognormal parameters has
occasionally been used, a thorough mini-
mum x2 test such as that which will be
described in this paper has never pre-
viously been attempted. The head and
neck data used by Berg (1965) was that
published by University College Hospital
(1958) for the treatment period 1946-50,
and the numbers of cancer deaths for
individual sites were very small. More
recent U.C.H. data is used in the present
study. The data of Wood and Boag
(1950) was also more recently followed up
by one of us (R.F.M.) in 1967, and was
re-tested for lognormality.
MATERIALS AND METHODS
To investigate adequately an analytical
form for the distribution of cancer death
survival times, all patients must have been
observed for at least 10 years subsequent to
treatment, otherwise, the " tail " of the
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distribution cannot be verified. Data from
the regional registries in England and Wales
are collated centrally by the Office ofPopula-
tion Censuses and Surveys (OPCS). Patients
are routinely followed up at intervals of 5,
10 and 15 years after the initial registration.
Those registrations relating to the period
1954-55 have recently been followed up and
15 year survival rates determined (OPCS,
1975). That part of the OPCS data relevant
to head and neck cancer was made available
to the authors in the form of individual
survival times of patients with proven
histology who eventually died with their
cancer present. Data were also obtained
from various Regional Cancer Registries but
only for a minimum follow-up period of
10 years.
Individual hospital cancer registries vary
wvidely in their methods of data collection,
storage and retrieval. In the best registries,
most treated cases will have been histologic-
ally verified and have well-recorded long
follow-ups, but there will often be the dis-
advantage that the numbers of cases for any
given treatment site are too small for this
type of study. This was overcome by
choosing 2 radiotherapy centres with a
large intake of patients, both of which have
excellent records dating back to the early
1930s. The Christie Hospital, Manchester
and the Royal Marsden Hospital, London are
probably the only 2 hospital registries in
the U.K. with such a wealth of reliable
information for head and neck cancer. The
3 London teaching hospitals chosen, West-
minster, University College and Middlesex,
did not always have sufficient numbers of
cases for analysis, and when this occurred,
the 3 sets of data were combined. Adden-
brooke's Hospital, Cambridge was chosen
since work on statistical models had already
been carried out at this centre (Haybittle,
1959).
The head and neck anatomical region was
chosen for this study since it contains the sites
of some cancers with a good prognosis, which
require a long term rather than short term
survival rate as a criterion for success of
treatment. Also, an earlier study had been
conducted by Wood and Boag (1950) using
Hammersmith Hospital data for the treat-
ment period 1934-45 for several individual
head and neck treatment sites, but the num-
ber of cases for each site was usually less than
50. In the more recent follow-up of this
data, the numbers of cancer deaths increased
only slightly.
Eight treatment sites within the head and
neck have been chosen for the study (Table I).
It was not usually possible to divide the data
into staged groups. The Wood and Boag
data (1950) contained all the sites in Table I
with the exception of pyriform fossa which
had been grouped with other sites under the
general heading ofpharynx. - Table II gives a
breakdown by registry and treatment site
ofsome 12,000 cases used inthis study. Only
the Christie Hospital and OPCS data have a
minimum follow-up period of 15 years.
Mathematical formulae.-Several analy-
tical forms have been proposed as a represen-
tation for the death rate (N(t), Fig. 1) of
cases who die with cancer present. They
have included the lognormal curve (equation
1), the negative exponential (equation 2) and
the skew exponential (equation 3).
N(t) - V2 .cxp (2x2)
where
log t-M
N(t) = a.exp (-at)
(1)
(2)
N(t) = No
It.exp (-y t) (3)
The actual survival time distribution of a
group ofpatients has been compared with the
postulated analytical form, choosing the
parameters (M and S for the lognormal;
a for the negative exponential; y and 4 for
the skew exponential) to give the best fit,
and using a computer to assess the goodness
of fit by a minimum x2 test.
MinimumX2 test-Agreement between the
observed survival time distribution and the
proposed formulae was tested by grouping
survival times into4-monthly periods between
0-1 year,* 6-monthly periods between 1-2
years, annual periods between 2-5 years and
longer periods thereafter, until a survival time
of 10 or 15 years subsequent to treatment
was reached. Observed and theoretical num-
bers in each interval were compared, using a
x2 test for the data in Table II and for 7
lognormal curves with fixed values ofS equal
* For small sample series these groups were sometimes combined, and the initial 2 periods changed to
0-6 months and 6-12 months.
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to 0-25, 0 30, 0 35, 0 40, 0-45, 0 50 and 0 55;
for the negative exponential and for 7
members of the skew exponential family
(equation 3) with 4 defined by equation (4),
w%Nhere r is integral and 1 < r < 7. This
4 = 2/(1+ r) (4)
restriction ensured that integration of equa-
tion (3) would lead to a complete gamma
function which could be easily evaluated.
The theoretical parameters (M, ox, y) were
varied stepwise until a minimum x2 wcas
found, and the computer then printed out
this value together w%Nith the corresponding
values of the parameters.
RESULTS
The data of Wood and Boag (1950)
with additional follow-up were tested
using the lognormal cutrves and the results
are given in Table III. The number of
cancer deaths in each group is too small
for any firm conclusions to be drawn, but
it does suggest that the lognormal may
provide a good fit for most sites, when a
value is assumed for the parameter S in
the range S 0 35-S- 045.
Each site in Table I will be considered
individually, since it was found that the
TABLE I. Treatment Sites
Antrtum
Floor of mouth
Larynx
Nasopharynx
Post cricoid
Pyriform fossa
Tongue
Tonsil
optimum range ofvalues for the lognormal
parameter S was not the same for all sites.
It was noted that although the lognormal
with S- 025 was tested, unlike some of
the Wood and Boag (1950) data of Table
III, none of the data in Groups A-L
(Table II) could be fitted by the S- 0-25
lognormal curve.
TABLE II. Grouping by Registry, Treatment Period and Site
Total cases for a given sito within the head arnd ineck wsho
(lie(l with their cancer present
Registry
OPCS
Christie Hospital,
Manchester
Royal Marsden
Hospital, Lod(lo
South Metropolitan
Regional Registry
Liverpool Regional
Registry
Birmingham
Regioinal Registry
Oxford Regionial
Registry
Addenbrooke's
Hospital,
Cambridge
Mid(dlesex Hospital,
London
University Collego
Hospital, Londlon
Westminster
Hospital, Lon(lon
Hammersmith
Hospital, Lon(don
(Wood and Boag,
1950)
Total cases for each
site
*1934-57
Treat-
ment
period Anitrum
1954-55 -
Tongue Larynx
5:37 242
Naso-
pharynx
194
Pyri-
form
fossa
174
Post
crico2(4
246
Floor
of
mouth
179
Group
refei orice
Tornsil letter
182 A
1945-58 222 700 449 175 142 203 219 139 B
1933-6:3
1958-63
1951-63
1957-63
1955-63
127
134
98
112
90 165 G
1945-65 44 153 97 31 38 87 43 41 H
1945-65 70
1945-65
1945-65
1934-45
27
41
25
183 143 66 41 29 41 58 J
77 80 21 42 39 19 27 K
33 101 14 28 51 30 22 L
103 31 64* 38 32 51
900 2942 2713 1097 1087 1270 975 1017
366 441 222 268 194 146 80 C
290 345 122 155 113 90 157 D
199 309 105 117 192 99 136 E
211 310 83 82 78 77 124 F
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The results refer to 63 different groups
of patients with between 6 and 11 groups
per site (Tables III-XII). The number
of cancer deaths/group was in the range
77-700, and one-third of the groups
contained more than 180 patients each.
In general, for the smaller groups, log-
normal distributions with several values
of S were found to give adequate fits,
whereas for the larger groups fewer fitted
the data. Nevertheless, for 6 of the 8
groups containing more than 300 patients
at least one value of S was found which
gave an adequate fit (P > 0.05) to a
TABLE III.-Goodness ofFit of the Wood and Boag (1950) Data to the Lognormals
Treatment No. of cancer
site deaths
Antrum 25
Floor of mouth 32
Larynx 31
Nasopharynx 64
Tongue 103
Tonsil 51
Post cricoid 38
No. of series for which a good fit
to the data is obtained (P>005)
P levels for different values of the lognormal parameter S
Notation: D signifies P>0 05
- signifies P<0* 05
S=0 25 S=0 30 S=0 35 S=0 40 S=0 45 S=0 50 S=0 55
0D 0D
0D
0)
09
01
0B
09
01
0B 0D 0D
(a
+3
0 0~ 0
+ -T-
2 3 6 7 6 4 3
In each case the symbol ((3 or -) in the table gives the result for a minimum goodness of fit test, for the
data on that horizontal level and the lognormal curve at the head of the vertical column.
TABLE IV.-Goodness ofFit of Antrum Data to the Lognormals
Group
reference letter
(see Table II)
C
F
JKL
E
D
B
P levels for different values of the lognormal parameter S
S 0 30 S=0 35 S=0 40 S=0 45 S=0 50 S=0 55
0 + 0~~~n n+ O __ @ @ @@~~~~~~~~~~~~4
0
0
Number of series out of 6 for
which a good fit to the data is
obtained (P>0 05) 5
09
5
Symbols as in Table III.
TABLE V. Goodness ofFit ofFloor of Mouth Data to the Lognormals
Group
reference letter
(see Table II)
F
JKL
C
E
D
A
B
P levels for different values of the lognormal parameter S
I~~~~~~~~~~~
S=0 30 S=0 35 S 0 40 S=0 45 S=0 50 S=
0(f (0 03 0a
G) (3) (a (3
- - 0( 0a 0
-(a (
=- = @~~~~~~( (3
Number of series out of 7 for
which a good fit to the data
is obtained (P>0 05)
Symbols as in Table III.
5
No. ofcancer
deaths
127
112
138
98
134
222
0)
0a
No. of cancer
deaths
77
90
146
99
90
179
219
=0*55
0
5 4
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TABLE VI.-Goodnes8 ofFit ofLarynx Data to the Loqnormat8
Group P levels for different values of the lognormal parameter S
No. of cancer reference letter
deaths (see Table II) S=0*30 S=0 35 S=0 40 S=0 45 S=0*50 S=0'55
97 H - - G G
80 K - G 3
143 J - 3
101 L -D- G
449 B - - 3 3
441 C - - -
165 G -D- -3
309 E -D- - 0
310 F - 33
242 A - --
345 D _ - _
Number of series out of 11 for
which a good fit to the data
is obtained (P > 0 05) - - 3 9 9 9
Symbols as in Table III.
TABLE VII.-Goodnes8 ofFit ofNasopharynx Data to the Lognormal8
Group P levels for different values of the lognormal parameter S
No. of cancer reference letter ,A-_ _ _-_ _
deaths (seeTableII) S=0 30 S=0 35 S=0 40 S=0-45 S=0 50 S=055
101 JKL -- 0 0 0 0 0
175 B - 0 0 0 0
83 F - -
194 A D -0
222 C -D - 33
122 D - - 0 0 0
105 E - -0 0 0 0
Number of series out of 7 for
which a good fit to the data is
obtained (P > 0 05) 1 5 7 7 7
Symbols as in Table III.
TABLE VIII.-Goodness ofFit ofPo8t Cricoid Data to the Lognormal8
Group P levels for different values of the lognormal parameter S
No. of cancer reference letter , -AK __
deaths (see Table II) S=0 30 S=0*35 S=0*40 S=0*45 S=0*50 S=055
119 JKL 0D 0 D - -
78 F - 0 0 0 0
203 B - 0 - -
194 C - - 0 0 03
113 D - D -
246 A -D- - 0
192 E - - 0 0 _
87 H D 0 0 0 0 -
Number of series out of 8 for
which a good fit to the data is
obtained (P > 0 05) 2 4 6 7 5 3
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TABLE IX.-Goodness ofFit ofPyriform Fossa data to the Lognormals
Group
No. of cancer reference letter
deaths (see Table II)
142 B
111 JKL
155 D
174 A
82 F
117 E
268 C
Number of series out of 7 for
which a good fit to the data is
obtained (P > 0 05)
P levels for different values of the lognormal parameter S
S=0 30 S=0 35 S=0 40 S=0 45 S=0 50
(3 (9 (D
(- (0 G3 03
0 03
03
3
0 0)
4
Symbols as in Table III.
TABLE X.-Goodness ofFit ofTongue Data to the Lognormals
Group
No. of cancer reference letter
deaths (see Table II)
77 K
153 H
199 E
211 F
183 J
366 C
537 A
290 D
700 B
90 G
Number of series out of 10 for
which a good fit to the data is
obtained (P > 0 05)
P levels for different values of the lognormal parameter S
S-=0 30 S=0 35 S=0 40 S=0 45
0_ 03
(9 (i)
_-
--00~~~~~~~(
--0 0~~~~~~~G
1 2 6
Symbols as in Table III.
TABLE XI.-Goodness ofFit ofTonsil Data to the Lognormals
Group
No. of cancer reference letter
deaths (see Table II)
139 B
182 A
157 D
136 E
107 JKL
124 F
80 C
Number of series out of 7 for
which a good fit to the data is
obtained (P > 0*05)
Symbols as in Table III.
P levels for different values of the lognormal parameter S
S=0*30 S=0*35 S=0 40 S=0 45 S=0*50 S=0*55
_ - 0 0 0 0
- - - 0 0 0
-- -0( 0 0
- - -0 (0 0
- -- 0D 0 -
_ - 03
- - - 0 - - _
1 6 5 5
lognormal distribution. Fig. 2 shows
2 examples of survival time distributions
fitted by lognormal curves.
It was found that for all 8 sites, at
least 2 lognormal curves fitted more
groups of observational data than did the
negative exponential curve. In com-
parison with the skew exponential curves,
the lognormal fitted at least 2 more data
groups for antrum, floor of mouth, larynx
and tongue. For nasopharynx, post
cricoid and pyriform fossa, however, the
0
S=0 55
0D
(a
2 3
S=0.50
3
S=0-55
2
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TABLE XII.-Goodness ofFit of all Data Groups to the Lognormals
Cancer- site
Antruim
Floor of mouth
Larynx
Nasopharynx
Post cricoi(l
Pyriform fo sa
TonIguel
Tonsil
Total nio.
of grouips
tested
6
I I
7.
10(
7
No. of grouips for which a goo(o fit to the (lata is obtained (P > 0 05),
for lognormal cuirves with different values assume(l for S
S' 0 30 S-0 035 S=-(04(0 S 0 45 80-\5(0 S-0 55
_ 9 5 5 4 @~~~~~~~~~415) 5j 4
3
4
.,
1
6
fi 4
1 g I I6 W6-
9 9 9 I
7 7 7
1 7 1 5 '3
3
3
lognormal fitted only one more data
group than the skew exponential curve.
Only for a single site, the tonsil, did one
skew exponential curve, = 0 33, fit
as many groups of data as a lognormal
curve. Thus, since negative exponential
and skew exponential curves offer only a
poor alternative to lognormal curves,
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(Data from Hospital B)
I I I I I
2 3 4 5 6 7
SURVIVAL TIME (years)
8
I I I -I
9 10 11 12
711 rACur nr rAMrep N: TWI TnA.I1F
(Data from
I o_ -
RLegir IF) iuryuut
Registry- F)
I I I I
2 3 4 5 6
SURVIVAL TIME (years)
7 i'o .
FiG. 2.-Distribution of survival times of patients who died with cancer present: histogram of
observations and theoretical lognormal curves.
--
25 -
20 -
I-
LO 1.0) ;z
0
.
CO
V)5
0-
o 10 -
CY
II
= 5-
cAr
t,I
' n Z U -
I i *
(
A--I IL-A
I I n
I I I II I
___j S _ i _ n mq. II_ ---AF.. I I
-
L
\
-*s
I P11-
__R. F. MOULD, T. HEARNDEN, M. PALMER AND G. C. WHITE
their results are not quoted in Tables
IV-xI.
For the groups which could not be
fitted by any lognormal curve, there was
no general explanation for the divergences
from lognormality. There was not, for
example, always an excess of mortality
in the first few months, which might
have been due to post-operative compli-
cations, neither was there always a poor
fit for long term cancer deaths. It is
possible, of course, that a subgrouping by
stage or by subsite might have produced a
large number of good (P > 0.05) fits to
the lognormal, but this was not possible
except for a few sites using the Christie
and Royal Marsden Hospitals data. An
additional complication was that for the
period under review, staging procedures
were not uniform throughout all centres.
Also, there was no universal agreement
as to the definition of subsites, and this
was particularly noticeable in the subsite
classification of laryngeal tumours.
Antrum
The lognormal curve with S in the
range 0 45-0 50 provided the best fit
to the data (Table IV). None of the
6 groups could be fitted by a negative
exponential, and 3 groups, B, D and
" JKL ", could not be fitted by any of
the skew exponentials. C = 0 5 was the
best skew exponential, fitting 3 groups.
Floor of mouth
The lognormal curve with S in the
range 0 45-0 50 provided the best fit
to the data (Table V). Only 2 of the
7 groups, F and "JKL ", could be
fitted by the negative exponential, and
3 groups, A, B and D, could not be fitted
by any of the skew exponentials.
- 0-5 was the best skew exponential
fitting 4 groups.
Larynx
The lognormal curve with S in the
range 0 45-0-55 provided the best fit
to the data (Table VI). Only 4 of the
11 groups could be fitted by a negative
exponential, G, H, J and K, and 4 groups,
A, B, D and F, could not be fitted by any
of the skew exponentials. C 0 4 was
the best skew exponential, fitting 7 groups.
The curve with C 0 5 fitted 6 groups.
Nasopharynx
The lognormal curve with S in the
range 0'45-0 55 fitted all 7 groups (Table
VII). Five groups were fitted by the
negative exponential, and 6 groups by
skew exponentials in the range C-0-29-
0 40. The curve with ( 0'5 fitted 5
groups.
Post cricoid
The lognormal curve with S- 045
provided the best fit to the data, with
S 0 40 only slightly worse (Table VIII).
Group H which could be fitted by most
lognormals was only fitted by asingle skew
exponential, that with C 1. The com-
bined group "JKL " was the only other
group fitted by the skew exponential
-1, and = 0 5 was the optimum
skew exponential, fitting 5 ofthe 8 groups.
The negative exponential fitted only 3 of
the groups, C, F and " JKL ".
Pyriform fossa
The lognormal curve with S = 0 40
fitted all but one of the 7 groups of data,
lognormal with S 0 45 failed to fit 3
groups (Table IX). Group C which could
not be fitted by any lognormal, was not
fitted by negative exponential or skew
exponentials. The negative exponential
fitted only 3 groups of data, A, D and
" JKL ", and the optimum skew exponen-
tial was = 0 5 which fitted 5 of the
7 groups.
Tongue
The lognormal curve with S - 0 45
provided the best fit to the data, 8 groups
out of 10, and S - 0 40 fitted 6 groups
(Table X). The 2 groups, B and G,
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which could not be fitted by any log-
normal were also not fitted by a negative
exponential or skew exponential. The
negative exponential fitted only 2 groups,
H and K. The optimum skew exponen-
tial was C 0 5, but this fitted only 5 of
the 10 groups. Data were also available
from the Trent Regional Registry, but
only for a minimum follow-up period of
5 years, as opposed to the 10 years for
the datain Table II. However, it is noted
that for this group of 142 cases with
limited follow-up, the lognormal provided
a fit in the range S 0 40-S = 0 45, as
did the negative exponential and the skew
exponentials in the range C 0 40-
= 0*67.
Forsomegroups (B, C, DandWoodand
Boag, 1950) it was possible to divide the
data into anterior two-third tongue
tumours and posterior one-third tongue
tumours. For the 4 available posterior
one-third tongue subgroups (No. of cancer
deaths - B: 195, C: 102, D: 71, Wood and
Boag: 65) the lognormal curve with S in
the range S=0 40-S = 0 50 fitted all
groups. Forthe anterior two-thirdtongue
subgroup, the numbers of cancer deaths
available were too small for analysis of
Group D (32 patients) and Wood and
Boag (44 patients). Of the remaining 2
groups, C with 177 cases was fitted by the
lognormal with S in the range S- 0 40-
S = 0.45, but neither the lognormals,
negative exponential nor skew exponen-
tials fitted Group B data of 506 cases. It
will be noted from Table X that the
combined Group B of tongue cancers
could not be fitted by any lognormal
curve.
Tonsil
The lognormal curve with S = 0 45
provided the best fit to the data, 6 out
of 7 groups (Table XI). For this site,
the skew exponential with C = 0 33 also
fitted 6 of the 7 groups. Skew exponen-
tials with C = 0-29 and C= 0 40 fitted 5
groups. The negative exponential fitted
only 3 groups, A, B and " JKL".
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CONCLUSIONS
The lognormal model with a value
assumed for the parameter S in the range
S 0= 035-S O040 has already been seen
to provide a useful alternative to the
actuarial method of calculating survival
ratesforseriesofcarcinoma cervixpatients,
even when follow-up data are sufficiently
extensive to allow the latter method to be
used (Mould and Boag, 1975;Mould, 1976).
In the present study for head and
neck cancer it has been shown that the
distribution of survival times of those
patients who die with their cancer present
can be reasonably represented by a log-
normal curve in a large proportion of the
patient groups. However, the range of
optimum values for the parameter S
differs with treatment site (Table XII).
The negative exponential and skew
exponential curves do not provide a
suitable alternative tothelognormal curve.
We are indebted to the many consul-
tant radiotherapists and medical records
staff of the OPCS, Regional Registries
(South Metropolitan, Liverpool, Birming-
ham, Oxford, Trent) and Hospital Regis-
tries (Addenbrooke's, Christie, Royal Mars-
den, Middlesex, University College, Ham-
mersmith, Westminster) who kindly gave
us access to and help in extraction of the
data on which this study is based. They
were so numerous that we hope they will
not take it amiss if we thank them in the
above manner, rather than by personal
mention.
We should also like to thank Miss A.
Corrigan of the Westminster Hospital for
assistance in processing the data and we
are very grateful to Miss V. S. Waters for
secretarial assistance.
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